Quantcast

Latest KaloBios Pharmaceuticals Inc. Stories

2015-04-22 20:24:51

SOUTH SAN FRANCISCO, Calif., April 22, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of veteran biopharmaceutical industry executive, Ronald A.

2015-04-06 08:29:27

SOUTH SAN FRANCISCO, Calif., April 6, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.

2015-03-16 16:26:07

SOUTH SAN FRANCISCO, Calif., March 16, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.

2015-02-03 16:25:46

SOUTH SAN FRANCISCO, Calif., Feb. 3, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.

2015-01-08 16:27:12

SOUTH SAN FRANCISCO, Calif., Jan. 8, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that David W.

2015-01-06 16:27:03

Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 6, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.

2014-11-11 16:25:58

KB004 Phase 1/2 Clinical Data in Hematologic Malignancies to be presented at the 56th American Society of Hematology Annual Meeting and Exposition SOUTH SAN FRANCISCO, Calif., Nov.

2014-11-06 16:35:58

SOUTH SAN FRANCISCO, Calif., Nov. 6, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.

2014-08-14 08:29:14

-- Anti-EphA3 Agents Inhibit Tumor Growth by Disrupting or Destroying the Tumor Microenvironment: Malignant Stem Cells, Stromal Cells, and New Tumor Vasculature -- SOUTH SAN FRANCISCO, Calif.,

2014-05-08 16:26:54

-- Provides Update on Clinical Programs and Timelines -- SOUTH SAN FRANCISCO, Calif., May 8, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.